Home Top News and Stories Business News Headlines CureVac COVID-19 vaccine records only 48% efficacy in final trial readout
Business News Headlines
0

CureVac COVID-19 vaccine records only 48% efficacy in final trial readout

0

CureVac COVID-19 vaccine records only 48% efficacy in final trial readout

wire-transfer-young-man-using-his-smartphone-laptop-banking-transaction_lores
now playing

Transferring money from UAE abroad: what are my cheapest options

WIN With Nespresso This Mother’s Day

NBA Playoffs 2022: A Casual Fan's Guide to the Postseason

Best New Climbing Gear of 2022

A Local Weekend Travel Guide to Austin, Texas

First Drive: 2022 Range Rover Ups the Luxury SUV Experience

Most Stylish Rain Jackets, Parkas, and Trench Coats for Men

EU eyes Russian oil import ban as Moscow strikes western Ukraine

World-class Clark Int’l Airport opens new 110,000 square-meter passenger terminal

PCG: Bodies of 5 children who drowned in Taal Lake found

   

CureVac COVID-19 vaccine records only 48% efficacy in final trial readout

CureVac said its COVID-19 vaccine was 48% effective in the final analysis of its pivotal mass trial, only marginally better than the 47% reported after an initial read-out two weeks ago. Read More

No related posts.

   

Follow us on Instagram

[instagram-feed]

Close

Share this video